Textbook Notes (368,432)
Canada (161,877)
Psychology (1,978)
PS268 (56)
Chapter 12

Drugs and Behaviour - Chapter 12

6 Pages
Unlock Document

Bruce Mc Kay

Drugs and Behaviour – Chapter 12  Natural health products o Health Canada responsible for establishing standards for safety and quality of all foods and drugs sold o Executes this mandate through the Food and Drugs Act (FDA) o Any substance “manufactured, sold or represented for use in diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or its symptoms in human beings or animals” is a drug o Natural health products – variety of substances formulated, packaged or promoted in similar manner to drugs but classified and regulated as foods o Health Canada’s concern is that natural products, while being promoted as therapeutic were classified as foods  Concerned with purity not efficacy  When NHPs classified as food, manufacturers had to provide evidence that food was safe and pure, no medical claims o NHP  Must be as safe as OTC products and do not need prescriptions  Health claims must now be supported by evidence  May include clinical trial data, references to published studies and pharmacopoeias an traditional resources  To constitute traditional resources – must have at least 50 consecutive years of use as medicinal ingredient o Represents 2 generations  Must have product licence  Some psychoactive natural health products o St. John’s wort  Used for centuries, known as devil’s scourge (prevent demonic possession)  Treat anxiety and depression  “to relieve restlessness or nervousness and help treat symptoms of sleep disorders”  Hypericum extract  Superior to placebo in patients with major depression  Similarly effective as standard antidepressants  Fewer side effects  People using it should notify physicians and pharmacists o SAMe  S-adenosly-L-methionine naturally occurring substance found in body  Active form of amino acid methionine (methyl donor)  SAMe tested as an antidepressant and recent summary analysis found more effective than placebo and no less effective than tricyclic antidepressants  “to help support healthy mood balance”  Ginkgo Biloba  Ginkgo regulated as NHP and sold with recommended uses o To improve memory and cognitive function, enhance circulation  Not completely clear which are the active agents and how effective it is for variety of uses for which it has been proposed  Reduces blood clotting, combining with blood thinner could be dangerous  May improve memory in Alzheimer’s because of its ability to improve circulation to brain  Safe as a stand-alone drug  Protects neurons against oxidative stress o Caffeine  Temporarily restore mental alertness or wakefulness when experiencing fatigue or drowsiness Brian Kwok 1 Drugs and Behaviour – Chapter 12  2004 – Caffeine-based stimulants transitioned from OTCs to NHPs  Number of OTC products contain caffeine in doses similar to cerebral stimulant NHPs  Not intended to be used as stimulant  Adjunct to analgesic ingredient o Weight-control products  None are licensed for sale in Canada  Phenylpropanolamine (PPA)  Psychoactive drug affective and considered safe and effective anorexic agent  PPA shown to increase blood pressure  Could lead to increased risk of hemorrhage stroke in women  Ephedra – misused in quest of weight loss  Used combination of ephedra and caffeine to lose weight o Linked with risk of cardiac death  Orlistat shown to help people lose some weight  Negative effects o Loose, oily stools o Frequent, urgent bowel movements o Flatulence o Sleep aids  Melatonin – hormone that helps increase total sleep time  Produced by pineal gland in humans  Circadian rhythm of endogenous melatonin release shown to be synchronized with habitual hours of sleep  O-T-C drugs o Medicines that may be sold directly to consumer without prescription o Drugs that are self-prescribed and self-administered for relief of symptoms of self-diagnosed illnesses  Extremely common in Canada o Regulated by Health Canada, ensuring ingredients are safe and effective  Determined by evaluation of active pharmaceutical ingredients o Spend more than $3 billion a year o Two biggest markets are aspirin-like analgesics and cough/cold/flu products o Exact number of OTC products on market is unknown o Regulations of OTC products  Before it can be sold in Canada, must seek Notice of Compliance from Health Canada  Drugs can be evaluated for both safety and effectiveness  Effectiveness – reasonable expectation that in significant proportion of target population, pharmacological effect of drug, when used under adequate directions will provide clinically significant relief of type claimed o Improved labeling of OTC drugs  Both safety and effectiveness of OTC drugs depends greatly on consumers using them according to directions and warnings on the label  Uniform standards for labels  Min. print size  Required topics  Bold bulleted headings indicating warnings  Clear concise language  Listing nonmedical ingredients on labels is important  OTC versus prescription drugs o Regulations pertaining to prescribing, distribution, selling and dispensing of drugs derive rom FDA and controlled drugs and substances act Brian Kwok 2 Drugs and Behaviour – Chapter 12 o National Association of Pharmacy regulatory authorities  3 categories of schedules  Schedule 1 – drugs that can be sold only with a prescription  Schedule 2 – drugs can be sold without prescription and kept behind counter  Schedule 3 – can be sold without prescription and displayed in pharmacy o Only difference between OTC and prescription is the greater amount of active ingredient in each dose o Prescriptions are chemicals unavailable OTC o Push to deregulate prescriptions drugs to OTC status  Growth in modern notions of individual responsibility and self-care  Pharmaceutical companies seeking increased sales  Growing challenges in maintaining public and private prescription drug plans o Behind the counter non-prescription drugs  Schedule 2 drugs can be sold without prescription but must be behind counter  Kept behind the counter because of adverse events that may occur  Gives opportunity for pharmacist to counsel patients about patients about proper use and precautions  Sleep Aids o Antihistamine – active ingredient in OTC sleep aids and cough/cold products o Scopolamine – acetylcholine receptor blocker o Methapyrilene accepted as sleep aid and scopolamine rejected  Caused cancer in lab animals, no longer safe o Pyrilamine maleate, then doxylamine succinate, then diphenhydramine o Sleep aids come in a variety of forms, recommended for relief of occasional sleeplessness o Diphenhydramine’s sedating effects derive from ability to block effects of histamine receptor sites in the CNS  Analgesics o Pain such a little word for such a big experience  Pain of varying intensities o Two major classes of drugs used to reduce pain or awareness of pain  Anaesthetics  Analgesics o People and pain  Anaesthetics – without sensibility  Reducing all types of sensation or by blocking consciousness completely  Analgesics – without pain  Reduce pain selectively without causing loss of other sensations  Pain is a complex psychological phenomenon  Two types of pain
More Less

Related notes for PS268

Log In


Join OneClass

Access over 10 million pages of study
documents for 1.3 million courses.

Sign up

Join to view


By registering, I agree to the Terms and Privacy Policies
Already have an account?
Just a few more details

So we can recommend you notes for your school.

Reset Password

Please enter below the email address you registered with and we will send you a link to reset your password.

Add your courses

Get notes from the top students in your class.